Evaluation of the diagnostic accuracy of the stop codon (SC) assay for identifying protein-truncating mutations in the BRCA1 and BRCA2 genes in familial breast cancer

Masato Sakayori, Masanori Kawahara, Kazuko Shiraishi, Tadashi Nomizu, Akira Shimada, Toshio Kudo, Rikiya Abe, Noriaki Ohuchi, Seiichi Takenoshita, Ryunosuke Kanamaru, Chikashi Ishioka

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Screening for protein-truncating mutations of the BRCA1 and BRCA2 genes is useful in genetic testing for familial breast cancer because, first, the methods are usually simple and not expensive, and second, the detected mutations indicate pathogenic mutations in general. We evaluated the diagnostic accuracy of the stop codon (SC) assay for detecting protein-truncating mutations in the BRCA1 and BRCA2 genes by comparing the results with DNA sequencing in samples from 29 patients with breast cancer from 24 Japanese families with a history of breast cancer. Protein-truncating mutations were detected in 5 of the 24 families (20.8%; two in the BRCA1 gene and three in the BRCA2 gene). Among the 176 DNA fragments examined using the SC assay, the existence of three protein-truncating mutations (one in the BRCA1 gene and two in the BRCA2 gene) was predicted correctly by the assay. Only one reverse transcriptase-polymerase chain reaction fragment was positive for the SC assay but was negative using DNA sequencing. Our study showed clearly that the SC assay is sensitive (3 of 3, 100%) and specific (172 of 173, 99%) for detecting pathogenic protein-truncating mutations in the BRCA1 and BRCA2 genes, and that it could be useful for screening larger populations.

Original languageEnglish
Pages (from-to)130-137
Number of pages8
JournalJournal of Human Genetics
Volume48
Issue number3
Publication statusPublished - 2003
Externally publishedYes

Fingerprint

BRCA2 Gene
BRCA1 Gene
Terminator Codon
Mutation
Proteins
DNA Sequence Analysis
Breast Neoplasms
Genetic Testing
Familial Breast Cancer
Reverse Transcriptase Polymerase Chain Reaction
DNA

Keywords

  • BRCA1
  • BRCA2
  • Familial breast cancer
  • Genetic testing
  • Stop codon assay

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Evaluation of the diagnostic accuracy of the stop codon (SC) assay for identifying protein-truncating mutations in the BRCA1 and BRCA2 genes in familial breast cancer. / Sakayori, Masato; Kawahara, Masanori; Shiraishi, Kazuko; Nomizu, Tadashi; Shimada, Akira; Kudo, Toshio; Abe, Rikiya; Ohuchi, Noriaki; Takenoshita, Seiichi; Kanamaru, Ryunosuke; Ishioka, Chikashi.

In: Journal of Human Genetics, Vol. 48, No. 3, 2003, p. 130-137.

Research output: Contribution to journalArticle

Sakayori, M, Kawahara, M, Shiraishi, K, Nomizu, T, Shimada, A, Kudo, T, Abe, R, Ohuchi, N, Takenoshita, S, Kanamaru, R & Ishioka, C 2003, 'Evaluation of the diagnostic accuracy of the stop codon (SC) assay for identifying protein-truncating mutations in the BRCA1 and BRCA2 genes in familial breast cancer', Journal of Human Genetics, vol. 48, no. 3, pp. 130-137.
Sakayori, Masato ; Kawahara, Masanori ; Shiraishi, Kazuko ; Nomizu, Tadashi ; Shimada, Akira ; Kudo, Toshio ; Abe, Rikiya ; Ohuchi, Noriaki ; Takenoshita, Seiichi ; Kanamaru, Ryunosuke ; Ishioka, Chikashi. / Evaluation of the diagnostic accuracy of the stop codon (SC) assay for identifying protein-truncating mutations in the BRCA1 and BRCA2 genes in familial breast cancer. In: Journal of Human Genetics. 2003 ; Vol. 48, No. 3. pp. 130-137.
@article{c959a0396ed043df846d9c5cabcb9fbb,
title = "Evaluation of the diagnostic accuracy of the stop codon (SC) assay for identifying protein-truncating mutations in the BRCA1 and BRCA2 genes in familial breast cancer",
abstract = "Screening for protein-truncating mutations of the BRCA1 and BRCA2 genes is useful in genetic testing for familial breast cancer because, first, the methods are usually simple and not expensive, and second, the detected mutations indicate pathogenic mutations in general. We evaluated the diagnostic accuracy of the stop codon (SC) assay for detecting protein-truncating mutations in the BRCA1 and BRCA2 genes by comparing the results with DNA sequencing in samples from 29 patients with breast cancer from 24 Japanese families with a history of breast cancer. Protein-truncating mutations were detected in 5 of the 24 families (20.8{\%}; two in the BRCA1 gene and three in the BRCA2 gene). Among the 176 DNA fragments examined using the SC assay, the existence of three protein-truncating mutations (one in the BRCA1 gene and two in the BRCA2 gene) was predicted correctly by the assay. Only one reverse transcriptase-polymerase chain reaction fragment was positive for the SC assay but was negative using DNA sequencing. Our study showed clearly that the SC assay is sensitive (3 of 3, 100{\%}) and specific (172 of 173, 99{\%}) for detecting pathogenic protein-truncating mutations in the BRCA1 and BRCA2 genes, and that it could be useful for screening larger populations.",
keywords = "BRCA1, BRCA2, Familial breast cancer, Genetic testing, Stop codon assay",
author = "Masato Sakayori and Masanori Kawahara and Kazuko Shiraishi and Tadashi Nomizu and Akira Shimada and Toshio Kudo and Rikiya Abe and Noriaki Ohuchi and Seiichi Takenoshita and Ryunosuke Kanamaru and Chikashi Ishioka",
year = "2003",
language = "English",
volume = "48",
pages = "130--137",
journal = "Journal of Human Genetics",
issn = "1434-5161",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Evaluation of the diagnostic accuracy of the stop codon (SC) assay for identifying protein-truncating mutations in the BRCA1 and BRCA2 genes in familial breast cancer

AU - Sakayori, Masato

AU - Kawahara, Masanori

AU - Shiraishi, Kazuko

AU - Nomizu, Tadashi

AU - Shimada, Akira

AU - Kudo, Toshio

AU - Abe, Rikiya

AU - Ohuchi, Noriaki

AU - Takenoshita, Seiichi

AU - Kanamaru, Ryunosuke

AU - Ishioka, Chikashi

PY - 2003

Y1 - 2003

N2 - Screening for protein-truncating mutations of the BRCA1 and BRCA2 genes is useful in genetic testing for familial breast cancer because, first, the methods are usually simple and not expensive, and second, the detected mutations indicate pathogenic mutations in general. We evaluated the diagnostic accuracy of the stop codon (SC) assay for detecting protein-truncating mutations in the BRCA1 and BRCA2 genes by comparing the results with DNA sequencing in samples from 29 patients with breast cancer from 24 Japanese families with a history of breast cancer. Protein-truncating mutations were detected in 5 of the 24 families (20.8%; two in the BRCA1 gene and three in the BRCA2 gene). Among the 176 DNA fragments examined using the SC assay, the existence of three protein-truncating mutations (one in the BRCA1 gene and two in the BRCA2 gene) was predicted correctly by the assay. Only one reverse transcriptase-polymerase chain reaction fragment was positive for the SC assay but was negative using DNA sequencing. Our study showed clearly that the SC assay is sensitive (3 of 3, 100%) and specific (172 of 173, 99%) for detecting pathogenic protein-truncating mutations in the BRCA1 and BRCA2 genes, and that it could be useful for screening larger populations.

AB - Screening for protein-truncating mutations of the BRCA1 and BRCA2 genes is useful in genetic testing for familial breast cancer because, first, the methods are usually simple and not expensive, and second, the detected mutations indicate pathogenic mutations in general. We evaluated the diagnostic accuracy of the stop codon (SC) assay for detecting protein-truncating mutations in the BRCA1 and BRCA2 genes by comparing the results with DNA sequencing in samples from 29 patients with breast cancer from 24 Japanese families with a history of breast cancer. Protein-truncating mutations were detected in 5 of the 24 families (20.8%; two in the BRCA1 gene and three in the BRCA2 gene). Among the 176 DNA fragments examined using the SC assay, the existence of three protein-truncating mutations (one in the BRCA1 gene and two in the BRCA2 gene) was predicted correctly by the assay. Only one reverse transcriptase-polymerase chain reaction fragment was positive for the SC assay but was negative using DNA sequencing. Our study showed clearly that the SC assay is sensitive (3 of 3, 100%) and specific (172 of 173, 99%) for detecting pathogenic protein-truncating mutations in the BRCA1 and BRCA2 genes, and that it could be useful for screening larger populations.

KW - BRCA1

KW - BRCA2

KW - Familial breast cancer

KW - Genetic testing

KW - Stop codon assay

UR - http://www.scopus.com/inward/record.url?scp=0037237077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037237077&partnerID=8YFLogxK

M3 - Article

C2 - 12624724

AN - SCOPUS:0037237077

VL - 48

SP - 130

EP - 137

JO - Journal of Human Genetics

JF - Journal of Human Genetics

SN - 1434-5161

IS - 3

ER -